Skip to main content
. Author manuscript; available in PMC: 2019 Mar 27.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2018 Jun 12;27(8):848–856. doi: 10.1002/pds.4565

FIGURE 4.

FIGURE 4

Histograms of time to sufficient accrued utilization in years to detect safety differences for implantable cardioverter defibrillators across adverse event and complication rates of 3.9, 6.1, and 12.6 events per 100 person‐years and rate ratios of 1.05, 1.15, 1.25, 1.50, and 2.00 for significance level α=0.05 [Colour figure can be viewed at wileyonlinelibrary.com]